In vitro stimulation of Bacteroides fragilis growth by Escherichia coli. 1982

J C Hagen, and W S Wood, and T Hashimoto

The interaction between Bacteroides fragilis and Escherichia coli was investigated by following their growth kinetics in an in vitro mixed culture system. In Bacto-peptone or in a semisynthetic medium (SSM-M) Bacteroides fragilis could initiate growth only when a small number of viable Escherichia coli initially coexisted for a short period of time. Both Bacto-peptone and SSM-M previously spent by Escherichia coli also allowed Bacteroides fragilis growth to occur but the supplementation of heat killed Escherichia coli cells or viable cell homogenates to fresh media failed to stimulate Bacteroides fragilis growth. The in vitro stimulation of Bacteroides fragilis growth by Escherichia coli observed in this study may be best explained by the combination of (a) removal of oxygen and other toxic substances and (b) de novo production of Bacteroides fragilis growth stimulating factor(s) by coexistent Escherichia coli.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D003956 Dialysis A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Dialyses
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000005 Abdomen That portion of the body that lies between the THORAX and the PELVIS. Abdomens
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D001442 Bacteroides Infections Infections with bacteria of the genus BACTEROIDES. Infections, Bacteroides,Bacteroides Infection,Infection, Bacteroides

Related Publications

J C Hagen, and W S Wood, and T Hashimoto
February 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
J C Hagen, and W S Wood, and T Hashimoto
May 2002, International journal of hygiene and environmental health,
J C Hagen, and W S Wood, and T Hashimoto
June 1985, The Journal of antimicrobial chemotherapy,
J C Hagen, and W S Wood, and T Hashimoto
March 1981, The Journal of antimicrobial chemotherapy,
J C Hagen, and W S Wood, and T Hashimoto
January 2014, Journal of paediatrics and child health,
J C Hagen, and W S Wood, and T Hashimoto
January 1989, Journal of medical microbiology,
J C Hagen, and W S Wood, and T Hashimoto
January 1985, Journal of clinical pathology,
Copied contents to your clipboard!